LINC01721
gene geneOn this page
Summary
LINC01721 (long intergenic non-protein coding RNA 1721, HGNC:52508) is a long non-coding RNA gene on chromosome 20p11.21.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52508 |
| Approved symbol | LINC01721 |
| Name | long intergenic non-protein coding RNA 1721 |
| Location | 20p11.21 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000230133 |
| Ensembl biotype | lncRNA |
| Entrez | 400839 |
| RNAcentral | URS00004EC2FD — lncRNA, 2376 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 lncRNA
ENST00000457274, ENST00000657180, ENST00000664459, ENST00000667083, ENST00000669143, ENST00000753590, ENST00000753591
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000457274 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001641483 | 24199767 | 24199834 |
| ENSE00001650057 | 24219623 | 24219702 |
| ENSE00001696844 | 24223704 | 24224588 |
| ENSE00001707060 | 24211349 | 24212691 |
Expression profiles
Bgee: expression breadth broad, 76 present calls, max score 75.28.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0849 / max 28.7072, expressed in 30 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183892 | 0.0849 | 30 |
Top tissues by expression
76 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.28 | gold quality |
| sural nerve | UBERON:0015488 | 68.40 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 62.32 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.23 | gold quality |
| prefrontal cortex | UBERON:0000451 | 59.50 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 57.44 | silver quality |
| frontal cortex | UBERON:0001870 | 56.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 54.69 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 54.33 | gold quality |
| cerebral cortex | UBERON:0000956 | 54.13 | gold quality |
| monocyte | CL:0000576 | 53.29 | gold quality |
| liver | UBERON:0002107 | 53.11 | gold quality |
| right lobe of liver | UBERON:0001114 | 52.65 | gold quality |
| endometrium | UBERON:0001295 | 52.46 | silver quality |
| brain | UBERON:0000955 | 51.81 | gold quality |
| right frontal lobe | UBERON:0002810 | 51.65 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 51.42 | silver quality |
| corpus callosum | UBERON:0002336 | 50.84 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 49.19 | gold quality |
| calcaneal tendon | UBERON:0003701 | 49.11 | silver quality |
| blood | UBERON:0000178 | 49.00 | silver quality |
| islet of Langerhans | UBERON:0000006 | 48.55 | silver quality |
| vermiform appendix | UBERON:0001154 | 48.20 | gold quality |
| muscle of leg | UBERON:0001383 | 47.95 | silver quality |
| adrenal tissue | UBERON:0018303 | 47.49 | silver quality |
| caudate nucleus | UBERON:0001873 | 47.22 | gold quality |
| multicellular organism | UBERON:0000468 | 45.78 | gold quality |
| small intestine | UBERON:0002108 | 45.70 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 45.39 | gold quality |
| gall bladder | UBERON:0002110 | 44.79 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.97 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.